Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma? | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Research Article

Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?

Online download statistics by month:

Online download statistics by month: December 2019 to October 2023

	Abstract	Full	Pdf
Dec 2019	2	2	0
Jan 2020	8	8	0
Feb 2020	13	13	0
Mar 2020	17	17	0
Apr 2020	19	19	1
May 2020	38	38	3
Jun 2020	20	20	5
Jul 2020	19	19	2
Aug 2020	14	14	6
Sep 2020	26	26	5
Oct 2020	26	26	15
Nov 2020	22	22	10
Dec 2020	29	29	8
Jan 2021	31	31	15
Feb 2021	20	20	10
Mar 2021	33	33	20
Apr 2021	32	32	21
May 2021	15	15	8
Jun 2021	25	25	10
Jul 2021	18	18	5
Aug 2021	18	18	8
Sep 2021	26	26	11
Oct 2021	12	12	21
Nov 2021	20	20	24
Dec 2021	24	24	19
Jan 2022	32	33	6
Feb 2022	30	33	19
Mar 2022	21	23	12
Apr 2022	26	28	12
May 2022	32	32	12
Jun 2022	17	17	6
Jul 2022	21	21	7
Aug 2022	25	27	9
Sep 2022	24	25	17
Oct 2022	24	24	13
Nov 2022	27	27	5
Dec 2022	14	14	1
Jan 2023	26	71	16
Feb 2023	28	29	10
Mar 2023	40	40	10
Apr 2023	21	21	9
May 2023	36	36	10
Jun 2023	34	34	12
Jul 2023	43	43	13
Aug 2023	15	15	8
Sep 2023	19	19	4
Oct 2023	47	47	26
Total	1129	1186	464